RNA sequencing resolves novel DYNC2H1 variants causing short‐rib thoracic dysplasia type 3: Case report
Molecular Genetics & Genomic Medicine · 2023
DOI: 10.1002/mgg3.2247 ↗Kurz gefasst
Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, 2023. Verfasst von Aren E Marshall und 7 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Cytoplasmic Dyneins, Short Rib-Polydactyly Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research, Ontario Genomics Institute.
Abstract (Originalsprache)
Background
Intronic variants outside the canonical splice site are challenging to interpret and therefore likely represent an underreported cause of human disease. Autosomal recessive variants in DYNC2H1 are associated with short‐rib thoracic dysplasia 3 with or without polydactyly (SRTD3), a clinically heterogeneous disease generally presenting with short ribs, shortened tubular bones, narrow thorax and acetabular roof anomalies. We describe a case of SRTD3 with compound heterozygous frameshift and intronic variants and highlight the essential role of RNA sequencing (RNA‐Seq) in variant interpretation.
Methods
Following inconclusive clinical genetic testing identifying a likely pathogenic frameshift variant and an intronic variant of uncertain significance (VUS) in DYNC2H1 in trans, the family enrolled in the Care4Rare Canada research program, where RNA‐Seq studies were performed.
Results
The proband presented with post‐axial polydactyly of all four limbs, a significantly small chest with a pectus excavatum and anterior flaring of the ribs. RNA‐Seq investigations revealed a novel splice junction as a result of the intronic VUS and significantly decreased DYNC2H1 gene expression in the proband.
Conclusion
This case demonstrates the diagnostic utility of RNA‐Seq for variant interpretation following inconclusive clinical testing, which can ultimately lead to diagnosis for patients with rare disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
- Centre for Computational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Department of Genetics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
- Newborn Screening Ontario, Ottawa, Ontario, Canada.
ORCID-Profile: Aren E Marshall
Förderung
- CIHR
- Canadian Institutes of Health Research
- Ontario Genomics Institute
Zitieren
APA
Marshall, A. E., MacDonald, S. K., Liang, Y., Couse, M., Care4Rare Canada Consortium, Boycott, K. M., Richer, J., & Kernohan, K. D. (2023). RNA sequencing resolves novel DYNC2H1 variants causing short‐rib thoracic dysplasia type 3: Case report. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2247
Vancouver
Marshall AE, MacDonald SK, Liang Y, Couse M, Care4Rare Canada Consortium, Boycott KM, et al. RNA sequencing resolves novel DYNC2H1 variants causing short‐rib thoracic dysplasia type 3: Case report. Molecular Genetics & Genomic Medicine. 2023. doi:10.1002/mgg3.2247
BibTeX
@article{Marshall2023,
author = {Marshall, Aren E and MacDonald, Stella K and Liang, Yijing and Couse, Madeline and Care4Rare Canada Consortium, Care4Rare Canada Consortium and Boycott, Kym M and Richer, Julie and Kernohan, Kristin D},
title = {RNA sequencing resolves novel DYNC2H1 variants causing short‐rib thoracic dysplasia type 3: Case report},
journal = {Molecular Genetics & Genomic Medicine},
year = {2023},
doi = {10.1002/mgg3.2247}
}
EUVIMED